Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

530.707
-2.141-0.40%
Number of Gainers:8
Number of Losers:24
Number of Flat:1
PE:- -
High:543.539
Open:532.796
Low:528.924
Close:532.848
Volume:64.68M
Turnover:1.56B
Market Cap:338.96B
Float Cap:302.02B

Loading ...

Morning Session Sees Market Divergence With ChiNext Up 1.41%, MLCC and Pharmaceuticals Lead Gains

Stock News
·
Yesterday

Hong Kong Stock Moves: Kintor Pharma-B (09939) Surges Nearly 9% Again, Subsidiary Signs Strategic Framework with Shanghai Kangmei for KT-939

Stock News
·
Yesterday

Hong Kong Stock Movers: Zai Lab Surges Over 7% on Q2 Revenue Growth and Analyst Optimism

Stock News
·
Yesterday

Morning Session Sees Chinese and Hong Kong Stocks Dip as Pharma Rallies and Space Tech Declines

Deep News
·
Yesterday

Hong Kong Shares Open Higher as Gold Stocks Rally, AI Application Stocks Gain Momentum

Deep News
·
Yesterday

LifeTech Scientific Leads These 3 Promising Asian Penny Stocks

Simply Wall St.
·
Yesterday

Antengene Sets Board Meeting to Review Interim Results

Reuters
·
Yesterday

Revenue Growth of Up to 23.1% Drives 19% Surge in PEIJIA-B Shares

Deep News
·
Aug 10

Biotech Firm JACOBIO-B Anticipates First-Ever Profit of at Least RMB 600 Million

Stock News
·
Aug 10

Ascletis Pharma Begins Obesity Drug Candidate Trial

MT Newswires Live
·
Aug 10

Jacobio Pharmaceuticals Sees Significant Growth in Hy Revenue

THOMSON REUTERS
·
Aug 10

Jacobio Pharmaceuticals - Expects Net Profit of not Less than Rmb600 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 10

Gold Jewelry Leads Consumer Recovery, AI-Driven Healthcare Continues Strong Momentum

Stock News
·
Aug 10

Market Trends Consolidate: Multiple Healthcare Stocks Display 'Pair' Patterns, Here's What It Could Mean

Deep News
·
Aug 10

Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: Asc36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and Asc36_35Fdc Once-Monthly Injection, a Co-Formulation of Asc36 and Glp-1R/Gipr Peptide Agonist Asc35

THOMSON REUTERS
·
Aug 10

Ascletis-B Launches Two Phase 1 Obesity Studies in the United States

Stock News
·
Aug 10

Ascletis Pharma - U.S. FDA Clears Ind Applications for Asc36 and Asc36_35Fdc

THOMSON REUTERS
·
Aug 10

Ascletis Says FDA Clears INDs for Obesity Candidates Asc36, Asc36_35fdc

Reuters
·
Aug 10

Record-Breaking Surge: WuXi Apptec Sets New Benchmarks, Reviving the Innovative Drug Sector’s Momentum? A New QDII Fund Launches to Capture the Opportunity

Deep News
·
Aug 10

Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next

Simply Wall St.
·
Aug 10